目的 探讨miR-146a对鼻咽癌耐顺铂细胞HNE-1/DDP顺铂敏感性的作用及可能机制。 方法 实验分空白组、阴性对照组及mimics-miR-146a组。MTT检测HNE-1/DDP细胞在不同方法处理后的增殖抑制作用;Annexin V-FITC/PI双染法检测细胞凋亡情况;Western blot检测周期蛋白CCNJ、MRP1、P-gp的相对表达水平;实时荧光定量PCR(RT-qPCR)检测CCNJ mRNA的相对表达水平。 结果 与其他两组相比,mimics-miR-146a组存活率降低,凋亡率升高,MRP1、P-gp、CCNJ蛋白表达量降低,CCNJ mRNA的相对表达量降低,差异均有统计学意义(P<0.05)。 结论 miR-146a可增加HNE-1/DDP对DDP的敏感性,机制可能是miR-146a抑制CCNJ的表达而调控下游蛋白MRP1、P-gp,降低细胞耐药性。
Abstract
Objective To investigate the effect of miR-146a on cisplatin sensitivity of nasopharyngeal carcinoma HNE-1 / DDP cells and its possible mechanism. Methods The experiment was divided into three groups: a blank control group, a negative control group and a mimics-miR-146a group. MTT assay was used to detect the proliferation inhibition of cells after different treatments. Annexin V-FITC / PI assay was used to detect apoptosis. Western blot was used to detect the relative expression levels of cyclin CCNJ, MRP1, P-gp. RT-qPCR was used to detect the relative expression level of CCNJ mRNA. Results Compared with other two groups, the survival rate, the relative protein expression levels of MRP1, P-gp, CCNJ and the relative expression level of CCNJ mRNA of mimics-miR-146a reduced, while the apoptosis rate increased. There were statistical differences in the survival rate, the relative protein expression levels of MRP1, P-gp, CCNJ, the relative expression level of CCNJ mRNA and the apoptosis rate among the three groups (P<0.05). Conclusions miR-146a can increase the sensitivity of HNE-1/DDP to DDP which mechanism may be through miR-146a inhibiting the expression of CCNJ to regulate downstream proteins MRP1,P-gp,and then to reduce cell resistance.
关键词
鼻咽癌 /
耐药性 /
微小RNA /
顺铂 /
细胞周期素蛋白J
Key words
Nasopharyngeal carcinoma /
Drug resistance /
Micro RNA /
Cisplatin /
Cyclin protein
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 陈德林. 鼻咽癌流行病学的研究与进展[J].中国肿瘤, 1992, (9): 20-21.
[2] 张亚运. 窄带成像诊断鼻咽癌准确性的系统回顾和Meta分析[D]. 无锡: 江南大学, 2018.
[3] Mcdermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma[J]. Clin Otolaryngol Allied Sci, 2010, 26(2): 82-92. DOI: 10.1046/j.1365-2273.2001.00449.x.
[4] Chen QY, Wen YF, Guo L, et al. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma:phase III randomized trial[J]. J Natl Cancer Inst, 2011, 103(23): 1761-1770. DOI: 10.1093/jnci/djr432.
[5] Ambros V. The functions of animal microRNAs[J]. Nature, 2004, 431(7006): 350-355. DOI: 10.1038/nature02871.
[6] Dai T, Hu Y, Zheng H. Hypoxia increases expression of CXC chemokine receptor 4 via activation of PI3K/Akt leading to enhanced migration of endothelial progenitor cells[J]. Eur Rev Med Pharmacol Sci, 2017, 21(8): 1820-1827. PMID: 28485797.
[7] Shi L, Xu ZZ, Wu G, et al. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J[J]. BMC Cancer, 2017, 17(1): 138. DOI: 10.1186/s12885-017-3132-9.
[8] Li N, Ma Y, Ma L, et al. MicroRNA-488-3p sensitizes malignant melanoma cells to cisplatin by targeting PRKDC[J]. Cell Biol Int, 2017, 41(6): 622-629. DOI: 10.1002/cbin.10765.
[9] Cheng RR, Lu CY, Zhang GJ, et al. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1[J]. Oncol Rep, 2017, 37(4): 2129-2136. DOI: 10.3892/or.2017.5505.
[10]Wang XH, Tang S, Le SY, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth[J]. PloS One, 2008, 3(7): e2557. DOI: 10.1371/journal.pone.0002557.
[11]He HL, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma[J]. Proc Natl Acad Sci U S A, 2005, 102(52): 19075-19080. DOI: 10.1073/pnas.0509603102.
[12]Pacifico F, Crescenzi E, Mellone S, et al. Nuclear factor-κB contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a[J]. J Clin Endocrinol Metab, 2010, 95(3): 1421-1430. DOI:10.1210/jc.2009-1128.
[13]Bhaumik D, Scott GK, Schokrpur S, et al. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells[J]. Oncogene, 2008, 27(42): 5643-5647. DOI: 10.1038/onc.2008.171.
[14]Zheng HL, Ma RQ, Wang QZ, et al. MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells[J]. Oncotarget, 2015, 6(29): 27805-27815. DOI: 10.18632/oncotarget.4738.
[15]邵倩倩, 马莹晔, 李慧, 等. MiR-139-5 p通过靶向CXCR4/PI3 K/Akt信号通路增强鼻咽癌DDP耐药细胞对DDP的敏感性[J]. 中华解剖与临床杂志, 2018, 23(2): 149-154. DOI: 10.3760/cma.j.issn.2095-7041.2018.02.013.
[16]Liu JY, Chen W, Chen ZZ, et al. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma[J]. Biomed Pharmacother, 2017, 93: 869-878. DOI: 10.1016/j.biopha.2017.06.094.
[17]Jiang CY, Wang HT, Zhou L, et al. MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4:[J]. Oncol Rep, 2017, 38(1): 82-88. DOI: 10.3892/or.2017.5641.
[18]孟凡磊, 王超, 霍晓川, 等. miR-146a促进动脉粥样硬化斑块形成调控机制研究[J]. 解放军医学院学报, 2014, 35(8): 847-849. DOI: 10.3969/j.issn.2095-5227.2014.08.020.
[19]王文俏, 刘露, 许馨, 等. miR-146a/b在动脉粥样硬化疾病中的研究进展[J]. 生命科学, 2015, 27(4): 471-476. DOI: CNKI:SUN:SMKX.0.2015-04-008.
[20]Althoff F, Viktorinová I, Kastl J, et al. Drosophila Cyclin J is a mitotically stable Cdk1 partner without essential functions[J]. Dev Biol, 2009, 333(2): 263-272. DOI: 10.1016/j.ydbio.2009.06.042.
[21]Kolonin MG, Jr FRL. A role for cyclin J in the rapid nuclear division cycles of early Drosophila embryogenesis[J]. Dev Biol, 2000, 227(2): 661-672. DOI: 10.1006/dbio.2000.9916.
[22]Venturutti L, Russo RIC, Rivas MA, et al. MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1[J]. Oncogene, 2016, 35(48): 6189-6202. DOI: 10.1038/onc.2016.151.
[23]Takano N, Hishida M, Inokawa Y, et al. CCNJ detected by triple combination array analysis as a tumor-related gene of hepatocellular carcinoma[J]. Int J Oncol, 2015, 46(5): 1963-1970. DOI: 10.3892/ijo.2015.2892.
[24]Harvey RC, Mullighan CG, Wang XF, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome[J]. Blood, 2010, 16(23): 4874-4884. DOI: 10.1182/blood-2009-08-239681.
基金
国家自然科学基金(81903142);安徽省高校自然科学研究重点项目(KJ2019A0293,KJ2019A0376);蚌埠医学院科技发展基金(BYKF1763);蚌埠医学院自然科学基金重点项目(BYKY1855ZD)